News & Analysis as of

Comment Period Advisory Committee

Farrell Fritz, P.C.

A Tool to Locate, But Not Analyze: Commercial Division Seeks to Adopt a New Rule Governing GenAI

Farrell Fritz, P.C. on

The Commercial Division Advisory Council (“Advisory Council”) is consistently looking to implement and amend new rules to enhance practice in the Commercial Division. On June 11, 2025, the Advisory Council proposed adding a...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Cal/OSHA Announces Discussion Drafts for Revised Wildfire Smoke Protection and Heat Illness Prevention Standards

On Friday, May 9, 2025, the California Division of Occupational Safety and Health (Cal/OSHA) announced discussion drafts for the wildfire smoke regulation, as well as the indoor heat and outdoor heat regulations. ...more

WilmerHale

PTAB/USPTO Update - January 2024

WilmerHale on

On January 4, the USPTO announced the appointment of new leaders for the agency’s policy and communications teams. Sharon Israel will serve as the Chief Policy Officer and Director for International Affairs, and Jack...more

BakerHostetler

Open for Comment: Businesses Can Now Submit Public Comments on the Proposed Federal Rule Addressing MDLs

BakerHostetler on

There is big news in the world of multidistrict litigation: On August 15, 2023, the public comment period opened on a new proposed amendment to the Federal Rules of Civil Procedure specifically addressing case management in...more

McDermott Will & Emery

Treasury Seeks Public Comments on Proposed Terrorism Risk Insurance Program Regulations

McDermott Will & Emery on

The US Department of the Treasury (Treasury) published an official notice on November 10, 2020, seeking comments from interested parties on proposed new rules promulgated under the latest version of the Terrorism Risk...more

Goodwin

FDA Announces Advisory Committee Meeting on Sandoz’s Etanercept Biosimilar

Goodwin on

We previously reported on Sandoz’s aBLA for a biosimilar of Amgen’s ENBREL (etanercept) and the related BPCIA litigation. The FDA’s Arthritis Advisory Committee announced this morning that it will hold a public advisory...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide